Login to Your Account



ZYFLO TO THE RESCUE?

Host-directed therapy shows preclinical success in TB

By Anette Breindl
Science Editor

Thursday, July 3, 2014
As increasing bacterial drug resistance threatens to usher in a post-antibiotic era, one strategy being explored is so-called host-directed therapy – trying to give the immune system of an infected person a leg up against what ails them.

To continue reading subscribe now to Science News

Learn More about Science News

Already a subscriber? Sign In or Buy now to activate your subscription